Faron Pharmaceuticals Oy (HEL:FARON)
2.050
+0.005 (0.24%)
At close: Oct 9, 2025
Faron Pharmaceuticals Oy Statistics
Total Valuation
HEL:FARON has a market cap or net worth of EUR 228.13 million. The enterprise value is 236.88 million.
Market Cap | 228.13M |
Enterprise Value | 236.88M |
Important Dates
The next estimated earnings date is Friday, November 28, 2025.
Earnings Date | Nov 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 113.34M |
Shares Outstanding | n/a |
Shares Change (YoY) | +55.54% |
Shares Change (QoQ) | +0.77% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 80.54M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -14.04 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -7.65 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.89
Current Ratio | 1.89 |
Quick Ratio | 1.73 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2.32 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -46.68% |
Return on Invested Capital (ROIC) | -119.01% |
Return on Capital Employed (ROCE) | -230.30% |
Revenue Per Employee | n/a |
Profits Per Employee | -967,125 |
Employee Count | 25 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -41,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.95% in the last 52 weeks. The beta is 1.05, so HEL:FARON's price volatility has been similar to the market average.
Beta (5Y) | 1.05 |
52-Week Price Change | -22.95% |
50-Day Moving Average | 2.29 |
200-Day Moving Average | 2.36 |
Relative Strength Index (RSI) | 34.72 |
Average Volume (20 Days) | 221,325 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -19.29M |
Pretax Income | -30.99M |
Net Income | -30.95M |
EBITDA | -19.10M |
EBIT | -19.29M |
Earnings Per Share (EPS) | -0.29 |
Balance Sheet
The company has 13.53 million in cash and 22.41 million in debt, giving a net cash position of -8.88 million.
Cash & Cash Equivalents | 13.53M |
Total Debt | 22.41M |
Net Cash | -8.88M |
Net Cash Per Share | n/a |
Equity (Book Value) | -16.25M |
Book Value Per Share | -0.15 |
Working Capital | 6.98M |
Cash Flow
Operating Cash Flow | -24.69M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
HEL:FARON does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -55.54% |
Shareholder Yield | n/a |
Earnings Yield | -13.57% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |